![Christopher Missling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Missling
Directeur/Membre du Conseil chez
ANAVEX LIFE SCIENCES CORP.
Fortune : 4 M $ au 31/07/2026
Profil
Christopher U.
Missling is currently Director at Anavex Life Sciences Corp.
since 2013.
Former positions include Chief Financial Officer at ImmunoGen, Inc., CFO & Senior Vice President-Strategic Operations at Curis, Inc., Head-Financial Planning at Aventis, Inc., and Head-Healthcare Investment Banking at Brimberg & Co. Education includes graduate and doctorate degrees from Ludwig-Maximilians-Universität München, an MBA from WHU-Otto Beisheim School of Management, and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/01/2026 | 1 510 165 ( 1,63 % ) | 4 M $ | 31/07/2026 |
Postes actifs de Christopher Missling
| Sociétés | Poste | Début |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Directeur/Membre du Conseil | - |
Anciens postes connus de Christopher Missling
| Sociétés | Poste | Fin |
|---|---|---|
Aventis, Inc.
 Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Corporate Officer/Principal | - |
| IMMUNOGEN, INC. | Directeur Financier/CFO | - |
Brimberg & Co.
 Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
| CURIS, INC. | Directeur Financier/CFO | - |
Formation de Christopher Missling
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Aventis, Inc.
Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Brimberg & Co.
Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WHU-Otto Beisheim School of Management
 WHU-Otto Beisheim School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anavex Life Sciences Corp.
 Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
